EI
ALXN

EDMP Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

EDMP Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,252
Closed -$2.44M – 55
2021
Q2 		$2.44M Sell
13,252
-40
-0.3% -$6.87K 2.55% 16
2021
Q1 		$2.03M Sell
13,292
-238
-2% -$36.8K 2.15% 21
2020
Q4 		$2.11M Sell
13,530
-44
-0.3% -$5.65K 2.89% 10
2020
Q3 		$1.55M Buy
+13,574
New +$1.46M 2.28% 20

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

EDMP Inc's ALXN Position: Q3 2021 in Review

EDMP Inc sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 13,252 shares — an estimated $2.44M sold.

EDMP Inc first reported a position in ALXN in Q3 2020 and held it in 4 quarters. The position peaked at $2.44M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • EDMP Inc reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • EDMP Inc sold 13,252 Alexion Pharmaceuticals shares in Q3 2021, an estimated $2.44M.
  • EDMP Inc first reported a position in Alexion Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • EDMP Inc's Alexion Pharmaceuticals position peaked at $2.44M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on EDMP Inc's 13F filing for Q3 2021, filed 20 Oct 2021.